Skip to main content
logo
Adaptimmune Therapeutics plc (MUN:473A)
Germany flag Germany · Delayed Price · Currency is EUR
0.0160
0.00 (0.00%)
At close: May 21, 2026

Adaptimmune Therapeutics Ratios and Metrics

Millions EUR. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
May '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Market Cap
6367169351,2473,042
Market Cap Growth
-65.26%-95.00%-23.42%-25.00%-59.01%-29.77%
Enterprise Value
-3.9725.51649.3830.011,0902,746

Price Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
May '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PE Ratio
0.291.30----
PS Ratio
1.256.98-17.9353.09571.77
PB Ratio
0.231.2963.4925.1216.6315.98
P/TBV Ratio
0.821.33210.8325.6017.4416.97
P/FCF Ratio
-----687.22
P/OCF Ratio
-----256.82

EV Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
May '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
EV/Sales Ratio
-4.98-15.9146.41516.07
EV/FCF Ratio
-----620.27

Financial Efficiency

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
May '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Debt / Equity Ratio
0.290.295.340.460.240.11
Debt / FCF Ratio
-----5.29
Net Debt / Equity Ratio
-0.37-0.37-5.93-2.83-2.09-1.56
Net Debt / EBITDA Ratio
0.080.180.480.811.152.20
Net Debt / FCF Ratio
0.100.101.100.861.06-66.95
Asset Turnover
0.040.0400.190.070.01
Inventory Turnover
0.9200---
Quick Ratio
1.641.642.562.663.706.38
Current Ratio
2.042.042.882.863.916.65
Return on Equity (ROE)
-341.38%-346.65%-652.56%-222.89%-104.63%-54.71%
Return on Assets (ROA)
-111.06%-50.16%-66.96%-56.80%-39.37%-34.09%
Return on Invested Capital (ROIC)
-855.78%-----
Return on Capital Employed (ROCE)
-156.88%-69.77%-90.29%-66.13%-47.40%-38.39%

Yields

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
May '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Earnings Yield
340.06%76.92%----
FCF Yield
-----0.15%
Buyback Yield / Dilution
-11.11%7.45%-46.39%-24.73%-3.47%-9.36%
Total Shareholder Return
-11.11%7.45%-46.39%-24.73%-3.47%-9.36%